在 2021, the global ticagrelor market stood at USD 1,422 百万. 复合年增长率为 6.8% 从 2022 到 2028, 预计价值将达到 ~USD 2,254 百万 2028, 根据 Gen Consulting 公司的一份新报告.

该行业报告提供了全球市场的市场预测, followed by a detailed analysis of the dosage, 给药途径, 应用, 最终用户, 和地区. The global market data on ticagrelor can be segmented by dosage: 90mg, 60mg. Ticagrelor market is further segmented by route of administration: nasogastric tube, 口服. 根据应用, the ticagrelor market is segmented into: acute coronary syndrome, cardiac surgery. 基于最终用户, the ticagrelor market also can be divided into: 门诊手术中心 (ASC), 医院 & 诊所, 其他的. Ticagrelor market by region is categorized into: 北美, 亚太地区, 欧洲, 世界其他地区 (排).

The competitive landscape of the market is highly consolidated and dominated by key players such as AstraZeneca plc.

以数据为中心的报告重点关注市场趋势, 各细分市场的现状和前景. 对主要地区进行全面的市场评估, 该报告对于现有参与者来说是宝贵的资产, 新进入者和未来投资者.

为什么购买这份报告?
– Get a detailed picture of the Global Ticagrelor Market
– Identify segments/areas to invest in over the forecast period in the Global Ticagrelor Market
– 了解竞争环境, 市场的领先参与者
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.